Prescription Required
Formulation: Aerosol
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Aerosol
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Bevespi Aerosphere contains two active ingredients, glycopyrrolate and formoterol fumarate. It is a prescription inhaler used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD).
COPD is a long-term lung condition that causes ongoing breathing problems because airflow in and out of the lungs becomes limited. Bevespi Aerosphere helps keep the airways open so breathing can become easier over time.
Bevespi Aerosphere is used to help control airflow obstruction in adults with COPD.
COPD is a group of lung conditions that can make it difficult to move air through the lungs. It usually develops gradually and may become worse over time.
Common symptoms of COPD can include:
Bevespi Aerosphere does not cure COPD, but regular use can help improve airflow and make breathing easier.
Chronic bronchitis is one of the conditions that may occur as part of COPD.
It involves long-term inflammation of the bronchial tubes, which are the airways that carry air into and out of the lungs. This inflammation can lead to swelling and increased mucus production.
People with chronic bronchitis may experience a persistent cough, mucus production, wheezing, or shortness of breath.
Bevespi Aerosphere helps relax the muscles around the airways so they remain more open, which may improve airflow and reduce breathing difficulty.
Emphysema is another condition commonly associated with COPD.
It damages the small air sacs in the lungs, called alveoli. These air sacs normally help move oxygen into the bloodstream and remove carbon dioxide from the body.
When the air sacs become damaged, it becomes harder to move air out of the lungs. This can cause shortness of breath, especially during physical activity.
Bevespi Aerosphere helps open the airways, allowing air to move more freely through the lungs.
Bevespi Aerosphere combines two long-acting bronchodilators. Bronchodilators are medicines that help open the airways by relaxing the muscles surrounding them.
The two ingredients work in different ways, providing a combined effect that helps keep the airways open for an extended period.
Glycopyrrolate
Glycopyrrolate belongs to a group of medicines called long-acting muscarinic antagonists, or LAMAs.
Certain chemical signals in the body can cause the muscles surrounding the airways to tighten. Glycopyrrolate blocks these signals.
By preventing the airway muscles from tightening, glycopyrrolate helps the airways remain more open and makes it easier for air to move through the lungs.
Formoterol Fumarate
Formoterol fumarate belongs to a group of medicines called long-acting beta2-adrenergic agonists, or LABAs.
It activates beta2 receptors located in the muscles surrounding the airways. This causes the muscles to relax and the airways to widen.
Formoterol works for an extended period, helping maintain improved airflow throughout the day when used regularly.
Combined Effect
Glycopyrrolate and formoterol work through different pathways, but both help relax and open the airways.
Using these medicines together can provide greater bronchodilation than either medicine alone for some patients.
This combined effect may help:
Bevespi Aerosphere is a maintenance inhaler. This means it should be used regularly every day as prescribed, even when you are feeling well.
Consistent use helps keep the airways open and control COPD symptoms over time.
Do not stop using Bevespi Aerosphere just because your breathing improves unless your healthcare provider tells you to stop.
Bevespi Aerosphere should not be used to treat sudden episodes of severe shortness of breath, wheezing, or chest tightness.
It is not a rescue inhaler.
If you experience sudden breathing problems, use the quick-relief inhaler prescribed by your healthcare provider. Seek medical attention if your rescue medication does not relieve your symptoms or if your breathing becomes significantly worse.
You may notice that breathing becomes easier as the medication helps keep your airways open. However, COPD is a long-term condition, so Bevespi Aerosphere must usually be used continuously to maintain its benefits.
Your healthcare provider may monitor your breathing, lung function, symptoms, and use of rescue medication to determine how well the treatment is working.
Contact your healthcare provider if your COPD symptoms become worse, you need your rescue inhaler more often than usual, or the medication seems less effective than before.
Use Bevespi Aerosphere exactly as prescribed by your healthcare provider.
Do not take more doses than recommended or use it more frequently in an attempt to improve your breathing faster. Using too much may increase the risk of serious side effects.
Bevespi Aerosphere is intended for COPD maintenance treatment and is not generally used to treat asthma.
Tell your healthcare provider about all medications you use, including other inhalers, because using similar long-acting bronchodilators together may increase the risk of side effects.
Regular follow-up with your healthcare provider is important to make sure your COPD treatment continues to work safely and effectively.
Use Bevespi Aerosphere exactly as prescribed by your healthcare provider. Using the inhaler correctly helps make sure the medicine reaches deep into your lungs, where it can work properly.
Bevespi Aerosphere is a maintenance inhaler, which means it should be used regularly every day. It is not intended to provide quick relief during a sudden breathing attack.
Before each dose, check that the mouthpiece is clean and free of dust or other material.
Shake the inhaler well before each puff. This helps mix the medication properly inside the canister.
Sit or stand upright when using the inhaler. This can make it easier to take a full, deep breath.
Before placing the inhaler in your mouth, breathe out as fully as you comfortably can.
Do not breathe out into the mouthpiece. Moisture from your breath may affect the inhaler.
Place the mouthpiece in your mouth and close your lips firmly around it.
Begin breathing in slowly and deeply through your mouth. At the same time, press down firmly on the canister to release one puff of medication.
Continue breathing in slowly and deeply until your lungs feel comfortably full.
Good coordination between pressing the canister and breathing in is important. If you have difficulty using the inhaler correctly, ask your healthcare provider or pharmacist to review your technique.
After breathing in the medication, remove the inhaler from your mouth.
Hold your breath for several seconds, or for as long as is comfortable. This gives the medication more time to settle in the airways.
Then breathe out slowly and gently.
If your prescribed dose requires a second puff, wait a short time before repeating the steps.
Shake the inhaler again before the second puff. Then breathe out fully, place the mouthpiece in your mouth, and inhale the medication slowly and deeply while pressing the canister.
Follow the exact number of puffs prescribed by your healthcare provider.
Bevespi Aerosphere works best when it is used regularly and consistently.
Continue using it even when you are feeling well or are not experiencing COPD symptoms. Regular use helps keep the muscles around the airways relaxed and helps maintain better airflow.
Do not stop using Bevespi Aerosphere without speaking with your healthcare provider, even if your breathing improves.
Bevespi Aerosphere should not be used to treat sudden episodes of shortness of breath, wheezing, or chest tightness.
It does not replace a quick-relief or rescue inhaler.
Keep your prescribed rescue inhaler available in case you develop sudden breathing symptoms.
If you suddenly have difficulty breathing, use your rescue inhaler exactly as prescribed.
Seek medical attention if your breathing does not improve after using your rescue medication, if your symptoms become severe, or if you need your rescue inhaler more often than usual.
An increased need for rescue medication may be a sign that your COPD is not well controlled.
Priming prepares the inhaler so that it delivers the correct amount of medication.
Priming Before First Use
A new Bevespi Aerosphere inhaler must be primed before you use it for the first time.
To prime the inhaler:
Shake the inhaler before each priming spray.
After the fourth spray, the inhaler is ready for your regular dose.
Re-Priming After a Period of Nonuse
If Bevespi Aerosphere has not been used for more than 7 days, it must be re-primed before you use it again.
Shake the inhaler well and release two sprays into the air, away from your face.
Shake the inhaler before each spray. After releasing two sprays, the inhaler is ready for your regular dose.
Why Priming Is Important
Priming helps fill the inhaler mechanism with medication so that each puff contains the appropriate amount.
If the inhaler is not properly primed, the first few sprays may not contain the expected amount of medication.
Keep the mouthpiece clean and dry. Follow the cleaning instructions supplied with your inhaler.
Do not place the metal canister in water.
Replace the mouthpiece cap after each use to help protect the inhaler from dust and debris.
Pay attention to the dose counter on the inhaler so you know how much medication remains.
Do not continue using the inhaler after the dose counter reaches zero, even if the canister still feels as though it contains medication.
Have a replacement inhaler available before your current inhaler runs out.
Do not take extra puffs or use Bevespi Aerosphere more often than prescribed. Taking more medication will not provide faster relief and may increase the risk of side effects.
Do not use another medicine containing a long-acting beta2-agonist or long-acting anticholinergic unless your healthcare provider specifically tells you to.
Contact your healthcare provider if your breathing becomes worse, your medication seems less effective, or you begin needing your rescue inhaler more often than usual.
Bevespi Aerosphere (Glycopyrrolate/Formoterol Fumarate) is available in the following forms and strength:
Some people may have an allergic reaction to Bevespi Aerosphere. Do not use this medication if you are allergic to glycopyrrolate, formoterol, or any of its ingredients.
Seek emergency medical attention if you develop signs of a serious allergic reaction, such as swelling of the face, lips, tongue, or throat, severe rash, hives, or difficulty breathing.
In rare cases, Bevespi Aerosphere may make breathing problems worse immediately after use. This is called paradoxical bronchospasm.
If you suddenly develop severe wheezing, chest tightness, or shortness of breath after using Bevespi Aerosphere, stop using it and use your rescue inhaler as directed. Seek medical attention right away.
Bevespi Aerosphere can cause side effects, and some may be serious.
Tell your healthcare provider if you develop new or worsening symptoms, especially a fast or irregular heartbeat, chest pain, severe dizziness, difficulty urinating, eye pain, or vision changes.
Bevespi Aerosphere is a maintenance inhaler and should not be used to treat sudden COPD symptoms.
Keep your prescribed rescue inhaler available for sudden shortness of breath, wheezing, or chest tightness. Seek medical attention if your rescue medication does not provide relief.
Use Bevespi Aerosphere with caution if you have a history of heart disease, abnormal heart rhythms, high blood pressure, or other cardiovascular problems.
Formoterol may increase heart rate or affect heart rhythm in some people. Your healthcare provider may monitor you more closely if you have an existing heart condition.
Glycopyrrolate may make it more difficult to urinate in some people.
Tell your healthcare provider if you have an enlarged prostate, bladder problems, or a history of urinary retention. Seek medical advice if you develop difficulty urinating or painful urination.
Tell your healthcare provider about all medications and supplements you use before starting Bevespi Aerosphere.
This includes prescription medicines, over-the-counter products, vitamins, herbal supplements, and other inhalers. Some medications may increase the risk of side effects or affect how Bevespi Aerosphere works.
Do not start, stop, or change another medication without speaking with your healthcare provider.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
There is limited information about the use of Bevespi Aerosphere during pregnancy and breastfeeding. Your healthcare provider will consider the potential benefits and risks before deciding whether this medication is appropriate for you.
No. Bevespi Aerosphere is not a rescue or quick-relief inhaler. It is used regularly to help control COPD symptoms over time. If you suddenly develop shortness of breath, wheezing, or chest tightness, use the quick-relief inhaler prescribed by your healthcare provider.
No. Bevespi Aerosphere is a prescription medication and may not be suitable for everyone. Tell your healthcare provider about any medical conditions you have, especially heart problems, urinary problems, glaucoma, or allergies. You should also tell them about all medications and supplements you use. Your healthcare provider will decide whether Bevespi Aerosphere is appropriate for you.
No. Bevespi Aerosphere does not contain a corticosteroid. It contains two long-acting bronchodilators: glycopyrrolate and formoterol. These medicines work in different ways to relax the muscles around the airways and help keep them open.
Bevespi Aerosphere begins opening the airways soon after inhalation. You may notice that breathing feels easier after starting treatment, but the medication works best when it is used regularly every day as prescribed. It is not intended to provide immediate relief during a sudden breathing attack.
Store Bevespi Aerosphere at room temperature, preferably between 68°F and 77°F (20°C and 25°C). Keep the inhaler away from excessive heat, open flames, and direct sunlight. Do not puncture or burn the canister. Keep Bevespi Aerosphere out of the reach of children and pets.
| Generic name: | Glycopyrrolate/Formoterol Fumarate |
|---|---|
| Formulation: | Aerosol |
| Strength(s): | 9/4.8mcg |
| Quantities Available: | 120doses, 360doses |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Bevespi Aerosphere (glycopyrrolate/formoterol fumarate) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Bevespi Aerosphere is available in inhalation aerosol form, with each inhalation delivering 9/4.8mcg. The typical prescription regimen involves two inhalations twice daily. For a 90-day supply, this means you would need 360 inhalations (4 inhalations per day x 90 days).
Yes, we sell glycopyrrolate/formoterol fumarate on our website. You can enjoy low prices when you order through us. To purchase glycopyrrolate/formoterol fumarate, you will need a valid prescription from your healthcare provider, as we require this to dispense the medication safely and appropriately. You have the option to submit your prescription by mailing it to us, faxing it, or uploading it securely through your online account.
Yes, we ship Bevespi Aerosphere (glycopyrrolate/formoterol fumarate) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Bevespi Aerosphere (Glycopyrrolate/Formoterol Fumarate). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Bevespi Aerosphere (Glycopyrrolate/Formoterol Fumarate).
REVIEWS